Full-Time

Lead Product Manager

Posted on 11/22/2025

Clarivate

Clarivate

10,001+ employees

Subscription analytics for research and IP

No salary listed

London, UK + 1 more

More locations: Sant Cugat del Vallès, Barcelona, Spain

Hybrid

Hybrid role; 2-3 days per week on-site in Barcelona.

Category
Product (1)
Requirements
  • Bachelor's degree and/or equivalent combination of experience within Life Sciences or biopharma business industry
  • 10+ years of experience, including 4+ years' experience in Product Management with a proven track record of successful product delivery
  • Deal-making or financial experience, including licensing negotiations, merger & acquisitions (M&A), deal evaluation, or deal economics and valuation within the Life Science industry
  • Excellent oral and written English communications
Responsibilities
  • Work with the Product Director to maintain and evolve the product roadmap for our established platform while identifying new product opportunities
  • Engage directly with pharma deal-makers to identify pain points, validate developments, and advocate for customer needs internally
  • Deliver roadmap alongside Technology and UX teams, manage product backlog and prioritization with available resources
  • Drive growth for the existing product and support expansion into new segments and related product portfolio
  • Partner with commercial teams on strategy, provide training and demos, track adoption metrics
  • Work with Marketing, Sales, and Customer Success teams to ensure product success
Desired Qualifications
  • Competitive intelligence or market research background in life sciences business space
  • Experience working in global, virtual teams
  • Familiarity with AI as a productivity tool and as a driver of product innovation and improvement
  • Passion for customer and data driven decisions
  • Ability to set priorities and be flexible in a changing environment

Clarivate provides subscription-based analytics platforms and services focused on bibliometrics, scientometrics, business and patent intelligence, and regulatory standards for researchers, organizations, and regulators. Its products, including Web of Science and Derwent World Patents Index, give access to citation and patent data through a subscription model, enabling users to search, analyze, and generate reports. It stands out by offering an integrated suite that spans academia, intellectual property, and regulatory domains, backed by long-standing, curated data and trusted brands. The goal is to help organizations accelerate innovation and protect and manage their intellectual assets through reliable data, analytics, and regulatory intelligence.

Company Size

10,001+

Company Stage

IPO

Headquarters

London, United Kingdom

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 free cash flow of $78.9M retires $143M debt, strengthening balance sheet.
  • Organic subscription growth of 1.7% drives 2026 revenue outlook of $2.30-2.42B.
  • Alma's Linked Open Data Editor boosts library BIBFRAME adoption since March 2026.

What critics are saying

  • Citi slashes price target to $2.80 citing AI disintermediation of Web of Science.
  • RBC cuts target to $3 over Life Sciences segment sale execution failures.
  • Google Patents commoditizes Derwent analytics, eroding IP revenue in 18-36 months.

What makes Clarivate unique

  • Cortellis integrates Anthropic Claude AI for biopharma regulatory workflows.
  • Web of Science Research Intelligence uses AI for funding and impact analysis.
  • Derwent and CompuMark provide specialized patent and trademark intelligence.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Flexible Work Hours

Remote Work Options

Company News

Yahoo Finance
Apr 11th, 2026
Clarivate integrates Anthropic's Claude AI into regulatory workflows for biopharma and biotech

Clarivate, a global information services and analytics company, is integrating its Cortellis Regulatory Intelligence data with Anthropic Claude's AI reasoning capabilities. The integration will provide biopharma, biotech, MedTech and clinical research organisations with AI-powered access to regulatory data through automated workflows. The partnership allows customers to build AI agents combining Clarivate's regulatory intelligence with internal data and approved external sources. The company aims to extend its trusted regulatory insights into AI ecosystems where critical decisions are made. Clarivate owns prominent brands including Web of Science, Cortellis and Derwent, helping clients manage patents, conduct academic research and accelerate drug development. The strategic integration aligns with the company's broader strategy of embedding its proprietary intelligence into enterprise AI platforms.

Yahoo Finance
Mar 27th, 2026
Clarivate eyes 2-3% growth in 2026 as AI integration drives $1B adjusted EBITDA

Clarivate, a global information services company, is experiencing robust growth driven by AI integration, CFO Jonathan Collins said at the Wolfe FinTech Forum on 10 March. The company's Annual Contract Value grew 2% in 2025, up from 1% in 2024, with projections of 2% to 3% growth in 2026. Organic recurring revenue rose 0.5% in 2025, with expectations of 1% to 2% growth in 2026. Adjusted EBITDA exceeded $1 billion in 2025, with a projected 200-basis-point margin expansion this year. The growth stems from enhanced AI integration across its products, which serve academic research, intellectual property management and life sciences sectors. Clarivate is focusing on subscription-based models, partner renewals and AI-driven innovation whilst pursuing leadership changes to boost performance.

Ex Libris Group
Mar 26th, 2026
A flexible approach to BIBFRAME cataloging with the Linked Open Data Editor now available in Alma.

A flexible approach to BIBFRAME cataloging with the Linked Open Data Editor now available in Alma. March 26, 2026 Clarivate is pleased to announce the General Availability of the Linked Open Data (LOD) Editor in Alma. The new editor enables libraries to create and manage BIBFRAME Works and Instances directly within Alma using a flexible, ontology-guided, form-based interface. Fully integrated into Alma workflows and repository searches, the editor guides catalogers through metadata creation based on the BIBFRAME ontology, while supporting the creation and management of templates that promote consistent metadata practices and improve interoperability with linked data standards. As part of existing Alma metadata workflows, libraries can create and edit BIBFRAME Work and Instance records without leaving the system they already use. The editor integrates linked data lookup services to support the use of authoritative identifiers and controlled vocabularies, helping improve metadata quality and enabling richer connections between library resources. Key capabilities of the Linked Open Data BIBFRAME Editor include: * Creation of BIBFRAME templates based on the ontology * User-friendly form interface for creating and editing Work and Instance records * Integrated linked data lookup services using Realtime API searches * Seamless integration into Alma cataloging workflows and repository searches * Out-of-the-box templates designed to support interoperability standards In addition, the editor includes enhancements that improve usability and support core BIBFRAME cataloging workflows within Alma: * Supporting cataloging mechanisms such as record locking, draft management, and Admin privileges to ensure data integrity and synchronization * Support for adding manual URIs and labels in lookup fields, providing full flexibility during cataloging * Improved navigation and actions within the editor to streamline the cataloging experience The Linked Open Data Editor was introduced through an early access program with participating institutions, whose feedback helped refine both functionality and user experience prior to general availability. With the release of the LOD Editor, Alma continues to expand its support for linked data workflows - providing libraries with a practical platform to learn, experiment with, and gradually adopt BIBFRAME cataloging within their existing systems, without disrupting established processes. This approach supports improved interoperability, metadata quality, and discoverability, while allowing institutions to move toward linked data at their own pace.

Ex Libris Group
Mar 22nd, 2026
Clarivate announces Knowledge Days at ELUNA 2026.

Clarivate announces Knowledge Days at ELUNA 2026. March 22, 2026 Clarivate has announced Knowledge Days at ELUNA 2026, a dedicated pre-conference training event hosted by Ex Libris, taking place in Los Angeles, California. The event will offer library professionals an immersive, hands-on learning experience focused on maximizing the value of Ex Libris solutions, including Alma, Primo VE, Linked Data, and BIBFRAME. With a refreshed agenda for 2026, Knowledge Days will go beyond foundational training to explore emerging technologies and advanced workflows. Sessions will highlight AI-powered capabilities, improved metadata management strategies, and next-generation discovery experiences designed to help institutions modernize library services. The event will feature deep-dive training sessions on Alma and Primo VE, along with discussions on innovations such as the AI Metadata Assistant and linked data initiatives. Attendees will benefit from practical, role-based learning opportunities tailored to both new and experienced users. Knowledge Days will take place ahead of the main ELUNA conference, allowing participants to build skills and confidence before the broader event begins. The program will also provide opportunities for direct engagement with Ex Libris experts through live demonstrations, workshops, and interactive discussions. Whether institutions are working to optimize discovery, enhance metadata workflows, or prepare for the future of linked data, Clarivate says Knowledge Days will equip participants with the tools and insights needed to move forward with confidence. Registration is now open, with limited spaces available.

Yahoo Finance
Mar 13th, 2026
Clarivate price targets slashed to $3 as analysts cite AI risks despite 10% free cash flow growth

Clarivate Plc has faced downward price target revisions from analysts, with Citi cutting its target to $2.80 from $4.25 and RBC Capital reducing its target to $3 from $5. Both firms maintained neutral ratings, citing concerns around AI disintermediation risk and execution challenges related to a potential Life Sciences and Healthcare segment sale. The company reported $617 million in fourth-quarter revenues, down from $663 million in the prior year period, reflecting the impact of divestitures. Full-year revenues totalled $2.455 billion compared to $2.556 billion in 2024. Despite solid free cash flow growth and guidance for approximately 10% free cash flow growth in fiscal 2026, analyst caution persists. Clarivate provides global information, workflow solutions and analytics across academia, government, intellectual property and life sciences sectors.

INACTIVE